Реальная практика проведения клинико-экономических исследований лекарственных средств, входящих в федеральную программу высокозатратных нозологий [PDF]
, 2022 Objective: to assess the compliance of the actual practice of conducting clinical and economic research with the requirements applicable in the Russian Federation (RF) when including drugs in the Federal Program of High-Cost Nosologies (HCN).Material and
A. A. Kurylev +9 more
core +2 more sources
Анализ доступности лекарственных препаратов для детей, нуждающихся в паллиативной медицинской помощи [PDF]
, 2021 Objective: to analyze the availability and affordability of pharmaceuticals for children in need of palliative care.Materials and methods. The price, affordability and physical availability of pharmaceuticals for children in need of palliative care were ...
D. Medvedeva M. +5 more
core +2 more sources
Единая система и классификация показателей для интегральной оценки результативности и эффективности организации оказания медицинской помощи на уровне субъекта Российской Федерации [PDF]
, 2023 Objective: development of a unified system and classification of indicators for an integral assessment of performance and effectiveness of the organization of medical care (MC) at the regional level in the Russian Federation (RF).Material and methods.
D. V. Lukyantseva +9 more
core +2 more sources
Неинвазивная вентиляция легких у больных с внебольничными пневмониями тяжелого течения [PDF]
, 2023 Acute respiratory failure (ARF) is the leading cause of death in hospitalized patients with severe forms of COVID-19. At the beginning of COVID-19 pandemic the starting respiratory protocol suggested early use of intubation and artificial lung ...
D. I. Korabelnikov +3 more
core +2 more sources
Анализ приобретения и месячной стоимости антигипертензивной терапии современными фиксированными комбинациями в регионах Дальневосточного федерального округа [PDF]
, 2021 Objective: analyzing the acquisition and monthly costs for patients on modern fixed-dose antihypertensive combinations in three regions of the Far Eastern Federal District.Material and methods. Intra-group analysis of retail of antihypertensive drugs for
E. E. Loskutova +3 more
core +2 more sources
Влияние полиморбидности у пожилых больных с фибрилляцией предсердий на «стоимость болезни» [PDF]
, 2019 Objective: to analyze whether comorbidity affects the cost of treatment and medical services in elderly patients with atrial fibrillation (AF). Materials and methods. We conducted a retrospective analysis of 98 patients with AF. Comorbidity was evaluated
M. V. Kazakovtseva +5 more
core +2 more sources
Клинико-экономический анализ применения комбинации «тиксагевимаб + цилгавимаб» для терапии коронавирусной инфекции COVID-19 [PDF]
, 2023 Objective: to evaluate the pharmacoeconomic feasibility of using monoclonal antibodies or their combinations vs standard therapy in patients with mild and moderate-severe COVID-19 in order to prevent the severe course of the disease.Material and methods.
E. A. Shabalina +7 more
core +2 more sources
Антимикробная терапия внебольничной пневмонии в реальной клинической практике стационара (клинические и экономические аспекты) [PDF]
, 2018 The aim is to study the clinical and economic components of antimicrobial therapy (AMT) of community-acquired pneumonia (CAP) in a hospital ptactice.Materials and methods.
M. Khazov V. +7 more
core +2 more sources
Фармакоэпидемиологический анализ и анализ межлекарственных взаимодействий в терапии хронической почечной и печеночной недостаточности [PDF]
, 2023 Objective: to perform pharmacoepidemiological and drug interaction analysis of pharmacotherapy for liver/kidney transplantation.Material and methods. The study was conducted on the basis of multidisciplinary hospital in Nizhny Novgorod, which provides ...
D. S. Fokina +7 more
core +2 more sources
Фармакоэкономическая эффективность применения препарата атезолизумаб в сравнении с другими ингибиторами PD-1 у пациентов с распространенным немелкоклеточным раком легкого после предшествующей химиотерапии [PDF]
, 2020 Aim: to evaluate the pharmacoeconomic efficacy of the application of the atesolizumab (PD-L1 inhibitor) preparation compared with other control point inhibitors (PD-1 inhibitors) in patients with advanced non-small cell lung cancer (NSCLC) after chemothe
I. N. Diyakov +3 more
core +2 more sources